Answer Capsule
Corebridge Financial is a mixed-to-good fit for marijuana users, not a clearly specialized one. Five of seven platforms named Corebridge during the ranking stage (71.4% of included platform responses), with an average listed rank of 5.0 and a best listed rank of 3. The strongest reason to consider it is its Select-a-Term product: independent sources report Preferred Plus non-tobacco rates for use of 8 or fewer days per month, Standard Non-Smoker rates for use up to several times per week, and 18 term-length options. The main limitation is that Corebridge does not publish a marijuana-specific underwriting manual, so treatment of frequency, method, medical versus recreational use, and vaping must be verified case by case.
Research Snapshot
| Field | Finding |
|---|---|
| Platform mentions in ranking stage | 5 of 7 platforms (anthropic, google, grok, kimi, perplexity) |
| Share of included platform responses | 71.4% |
| Average listed rank | 5.0 |
| Best listed rank | 3 |
| Relevant product/model/plan | Corebridge Select-a-Term term life insurance, with Corebridge Direct term and permanent alternatives |
| Overall use-case fit | Good (4 platforms); Mixed (2 platforms); Uncertain (1 platform) — 7 platforms analyzed |
| Research date | 2026-09-22 |
Why Corebridge Financial Qualified for This Study
Questions This Section Answers
- Is Corebridge Financial a good choice for life insurance for marijuana users?
- How often did AI platforms recommend Corebridge Financial for marijuana users in 2026?
Corebridge Financial qualified because five of the seven included platforms named it during ranking discovery, giving it a 71.4% platform share and an average listed rank of 5.0 (best rank 3). It was the fourth-ranked finalist in the study. Platform fit ratings were not unanimous: anthropic, google, grok, and kimi rated the fit "good," openai and perplexity rated it "mixed," and deepseek rated it "uncertain" (anthropic, google, grok, kimi, openai, perplexity, deepseek).
The company sells term and permanent life insurance, quote access, and policy servicing through its life portal [1]. Corebridge Direct presents term life insurance with generally 10- to 30-year terms, fixed-premium options, and fixed death benefits, and identifies Select-a-Term (SAT) as a term product available in state-specific forms [2]. Independent coverage reports 18 Select-a-Term length possibilities, including 10 years, terms from 15 through 30 years, and 35 years [3].
Corebridge's insurance subsidiaries hold high financial-strength ratings from independent rating agencies [6], and one independent review reports an A (Excellent) AM Best rating and a ninth-place ranking in U.S. term life insurance sales [7]. These are company and third-party claims, not independently verified by this study.
The Product, Model, Plan, or Service Most Relevant to Life Insurance for Marijuana Users
Questions This Section Answers
- Which Corebridge Financial product should a marijuana user choose for term coverage?
- Does Corebridge Select-a-Term allow conversion to permanent coverage for marijuana users?
Corebridge Select-a-Term is the product most relevant to this use case, with Corebridge Direct term and permanent life insurance as alternatives. Every platform that named a product pointed to Select-a-Term or Corebridge term and permanent policies (openai, anthropic, deepseek, grok, kimi, perplexity, google).
Select-a-Term offers 18 term length options (10 years, 15–30 years annually, and 35 years), coverage from $100,000 to over $1 million, and convertibility to permanent coverage [8]. Corebridge Direct lists permanent options including guaranteed-issue whole life, whole life, universal life, and indexed or guaranteed universal-life products; guaranteed-issue coverage may avoid medical questions but is generally limited in amount and may not be the most cost-effective solution [12]. One independent review describes indexed universal life products and Secure Lifetime GUL 3 with lifetime death benefit guarantees [14].
Corebridge says its application process is streamlined and can produce an underwriting decision and policy delivery in 24–48 hours [15]. Agile Underwriting+ (AU+) is described as lab-free, no-exam underwriting for term policies up to $1 million, with over 60% of term applications qualifying, though final decisions may still require labs or records [17]. One review cautions that the SimpliNow Choice real-time approval system is "often unreliable" for complex profiles and vague in decline reasons [17].
What the AI Platforms Agreed About
Questions This Section Answers
- What do AI platforms agree on about Corebridge Financial for marijuana users?
- Does Corebridge Financial treat marijuana users as non-smokers?
Platforms broadly agreed that Corebridge is a mainstream, financially strong carrier with flexible term coverage, and that its marijuana treatment is frequency-based rather than a flat tobacco classification. This agreement is strong but not unanimous, and it rests largely on third-party and broker-channel sources rather than Corebridge's own published underwriting manual.
Recurring points of agreement:
- Frequency thresholds. Multiple platforms reported that adults using marijuana 8 or fewer days per month may qualify for the best rate class, while heavier use is declined or rated up [19].
- Non-smoker treatment for infrequent users. Corebridge treats infrequent marijuana users as non-smokers and offers affordable rates, especially for young people [27]. Select-a-Term offers standard non-smoker rates to applicants using cannabis up to several times per week [29].
- Medical marijuana is rated on the underlying condition. Rating for medical marijuana use is based on the underlying condition rather than marijuana use itself, and well-controlled conditions can result in standard rates [27].
- Product flexibility. Select-a-Term's duration range and conversion rights were cited across platforms [35].
- Financial strength. Corebridge's insurance subsidiaries hold high financial-strength ratings [39].
Agreement among AI platforms does not establish product quality or underwriting outcomes. These are platform-reported findings drawn from third-party reviews, broker-distributed guides, and company marketing pages.
Where the AI Platforms Disagreed or Were Uncertain
Questions This Section Answers
- Is Corebridge Financial's marijuana underwriting policy publicly documented?
- How does Corebridge Financial treat vaping marijuana compared with smoking or edibles?
The largest uncertainty is that Corebridge does not publish a marijuana-specific underwriting guideline. OpenAI found no current Corebridge public source stating how underwriting varies by marijuana frequency, method, recreational versus medically documented use, cannabis disclosure, THC testing, or tobacco-rate classification [41]. Deepseek reached the same conclusion: the public site reviewed does not publish a marijuana-specific underwriting guideline [44]. Perplexity noted that cannabis underwriting thresholds are mainly reported by third parties and an attributed field guide rather than clearly published, current official policy [45].
Specific conflicts and gaps:
- Frequency thresholds conflict. RiskQuoter states monthly users up to 8 times per month may get Preferred Plus with Corebridge, while MarcAn's table shows 3–4 times per month as Preferred-to-Standard Non-Smoker [47]. These may reflect different time periods, product lines, or health-profile assumptions.
- Vaping treatment. Google reported that vaping marijuana automatically results in Standard Tobacco rates at best [50]. Grok reported vaping often results in Standard Tobacco rates at best, with minor variation across guides [51]. OpenAI stated Corebridge's treatment of vaping is unclear from public materials [41].
- Term length details conflict. Public sources conflict on whether Corebridge term products run 10–35 years with annual increments or a narrower term set in some reviews [45].
- Complaint data conflict. One source reports a complaint level 50%+ lower than the industry average (0.45 vs 1.0), while the same and other sources report total complaints almost 3 times higher than the industry average [56]. NerdWallet reports higher-than-expected complaint volume and low customer-satisfaction performance [43].
- Recent underwriting tightening. As of 2024–2025, Corebridge shows less aggressive offers for impaired risk, and previously favorable niches such as heart disease are now inconsistent [58].
- Identity and issuing insurer. The supplied domain identity was not independently resolved beyond the Corebridge Financial site and Corebridge Direct product materials; the exact legal issuing insurer must be verified on the application and policy [41]. The normalization audit also noted conflicting official domains and an unresolved identity.
Use-Case-Specific Features and Capabilities
Questions This Section Answers
- What features make Corebridge Financial worth considering for a marijuana user who wants flexible term lengths?
- Does Corebridge Financial offer no-exam underwriting for marijuana users?
Corebridge's most relevant capabilities for this buyer are term-length flexibility, accelerated underwriting, conversion rights, and condition-based rating for medical marijuana users. Each carries a verification requirement.
| Capability | What platforms reported | Evidence strength |
|---|---|---|
| Term length flexibility | 18 Select-a-Term options, 10–35 years; $100,000 to $1M+ coverage | Independent reviews |
| Accelerated underwriting | AU+ lab-free, no-exam up to $1 million; 60%+ of term applications qualify | Independent review |
| Decision speed | Underwriting decision and policy delivery in 24–48 hours | Company page |
| Conversion | Select-a-Term convertible to permanent coverage within a specified timeframe | Independent and company sources |
| Medical marijuana | Rating based on underlying condition; well-controlled conditions may get standard rates | Independent journalism |
| Permanent alternatives | IUL, GUL, guaranteed-issue and simplified-issue products cited | Independent reviews |
Frequency and method drive the outcome. For weekly users, Preferred and Standard rates are available with a negative THC test; daily users face higher underwriting scrutiny and table ratings of 50–100% above standard rates [59]. Grok reported that use exceeding 16 days per month or 4+ days per week is typically declined, and that individuals employed in marijuana-related businesses face automatic decline [61]. Those thresholds come from broker-distributed and third-party guides, not from Corebridge's own published manual.
Applicants must truthfully disclose marijuana use; a positive THC test after denying use results in application decline [63]. Cannabis testing is increasingly common in underwriting, and a positive result or a "yes" answer to a marijuana question triggers rating decisions [64].
Pricing, Fees, Contracts, and Ongoing Costs
Questions This Section Answers
- How much does Corebridge Financial cost per month for a marijuana user, and are there marijuana-specific fees?
- What contract terms and cancellation rights apply to Corebridge Select-a-Term?
No verified marijuana-user-specific premium exists in the supplied evidence, and pricing confidence is low across platforms. Corebridge Direct advertises $250,000 of term coverage as low as $13 per month, but the example assumes a 35-year-old applicant in the Preferred Plus underwriting class; it is not a marijuana-user quote and should not be used as an expected price [65]. NerdWallet reports that Corebridge term rates are relatively competitive, but its published examples are for nonsmokers in excellent health [66].
Known cost factors:
- Final premiums depend on the underwriting class, age, coverage amount, term, health, lifestyle, occupation, and driving record [65].
- Smoker classifications can exceed 200% of non-smoker premiums [67].
- Daily users may face table ratings adding 50–100% above standard rates [68].
- No-exam AU+ coverage often carries higher premiums for the same face amount than exam-based underwriting [69].
- Policy riders (chronic illness, critical illness, terminal illness, child rider) may increase premiums, and availability varies by state [69].
- An accelerated death benefit rider for terminal illness is automatically included on Select-a-Term [69].
- No marijuana-specific fee was publicly verified, and exact policy charges, rider costs, reinstatement costs, and any underwriting-related examination costs were not verified [65].
Contract terms: Select-a-Term is convertible to permanent coverage within a specified timeframe and renewable annually until age 95 at the end of the term [69]. Term coverage lasts for the selected period, and premiums may increase after the guaranteed level-premium period if the policy is renewed [65]. Conversion rights and deadlines depend on the policy form and state [65]. Free-look and cancellation rights are state- and contract-specific; free-look periods of 10–30 days depending on state were reported [67]. The contestability period is typically 2 years from issue, during which the insurer may investigate the application [69]. A disability waiver is available that waives a portion of premium if totally disabled for 6+ months [69].
Best Suited For
Questions This Section Answers
- Who is Corebridge Financial best suited for among marijuana users?
- Is Corebridge Financial a good fit for a monthly marijuana user who wants Preferred Plus rates?
Corebridge is best suited to infrequent-to-moderate marijuana users in otherwise favorable health who want flexible, fully underwritten term coverage and are willing to verify underwriting terms before applying. Platform fit ratings split four "good," two "mixed," and one "uncertain," so this is a qualified recommendation rather than a consensus endorsement.
Best-considered-for profiles reported across platforms:
- Occasional users (a few times per year) seeking non-smoker rates [71].
- Monthly users (up to 8 times per month) who may qualify for Preferred Plus rates [73].
- Moderate users (up to several times per week) who may qualify for Standard Non-Smoker rates [77].
- Applicants wanting flexible term lengths (10–35 years) with conversion to permanent coverage [80].
- Applicants seeking rapid underwriting and 24–48 hour policy delivery [83].
- Medical marijuana users with well-controlled underlying conditions [71].
- Applicants with pre-existing conditions such as diabetes, heart disease, or chronic kidney disease who use marijuana [85].
- Buyers who prefer agent-assisted underwriting over a purely online instant decision [87].
Probably Not Best Suited For
Questions This Section Answers
- Who should not choose Corebridge Financial for life insurance as a marijuana user?
- Is Corebridge Financial a poor choice for daily marijuana users or vapers?
Corebridge is probably not the best fit for daily or heavy users, vapers, applicants who need published cannabis underwriting rules before applying, or buyers who need guaranteed approval. These limits were reported consistently across platforms, though the underlying thresholds come from third-party and broker-channel sources rather than Corebridge's own manual.
- Daily or heavy users. Daily users face higher scrutiny and table ratings of 50–100% above standard rates; use exceeding 16 days per month or 4+ days per week is typically declined [89].
- Vapers. Vaping marijuana often results in Standard Tobacco rates at best [91].
- Applicants who need published cannabis rules. Corebridge's public materials do not verify marijuana-specific underwriting classes or treatment of medical versus recreational use [94].
- Applicants unwilling to disclose use. Material misrepresentation, such as a positive THC test after denying use, results in application decline [98].
- Buyers needing guaranteed issue. No guaranteed-issue option for marijuana users was identified in the supplied evidence; all coverage described requires medical underwriting [99].
- Applicants with complicating factors. Substance-use history, psychiatric conditions, driving violations, or medical issues may complicate underwriting, and Corebridge's exact treatment is unclear [94].
- Applicants employed in marijuana-related businesses. One platform reported automatic decline for these applicants [91].
- Buyers prioritizing documented customer service. Independent reporting identifies complaint and customer-satisfaction concerns [96].
When Another Option May Be Better
Questions This Section Answers
- What is a better alternative to Corebridge Financial for a daily marijuana user who needs non-smoker rates?
- When should a marijuana user choose a different carrier instead of Corebridge Financial?
Another option may be better when the buyer's use pattern, method, or documentation needs fall outside what Corebridge is reported to accommodate. Platforms named specific alternatives, and these are platform-reported comparisons rather than verified carrier rules.
- Daily users seeking better rates: Lincoln Financial was described as explicitly classifying marijuana as non-tobacco and offering more favorable pricing for daily users (anthropic). Prudential was described as offering non-tobacco rates to non-daily users (anthropic).
- Medical marijuana users: John Hancock was described as having written cannabis-friendly guidelines, and Lincoln Financial as differentiating by frequency and method (anthropic).
- Non-daily users wanting maximum flexibility: Prudential and Mutual of Omaha were described as offering similar flexibility (anthropic).
- Guaranteed-issue coverage: Colonial Penn, TruStage, and Gerber Life were named for guaranteed-issue final expense policies (anthropic).
- Fully online comparison shopping: Ethos was described as providing a guided online application with multi-carrier comparison without agent involvement (anthropic).
- Complex health or cannabis profiles: Specialist cannabis underwriting brokers were recommended to identify the optimal carrier match (anthropic).
- Vapers wanting to avoid tobacco rates: Other carriers may offer non-tobacco rates for vaping (google).
- Generous frequency thresholds: Principal was described as offering "super-preferred" rates for up to 2 times per month, and Nationwide as offering "preferred-plus nontobacco" for up to 2 times per week with no alcohol or drug abuse and no DUIs [102].
- State availability limits: Verify product and plan availability in your state before pursuing Corebridge [104].
For a broader view of how carriers compare on this use case, see the Life Insurance for Marijuana Users consensus index. Buyers comparing across health conditions and high-risk categories can also browse the wider life insurance directory.
Questions to Verify Before Buying
Questions This Section Answers
- What should a buyer confirm with Corebridge Financial before signing a marijuana-user life insurance contract?
- Does Corebridge Financial require a THC test for marijuana users?
These questions come from the supplied platform research and should be answered in writing before an application is submitted.
- Does Corebridge classify marijuana as tobacco, non-tobacco, or a separate underwriting category [105]?
- What underwriting class applies to the applicant's exact frequency and method of use, including smoking, vaping, edibles, concentrates, or occasional use [105]?
- Does medically documented cannabis use receive different treatment from recreational use, and what documentation is required [105]?
- Are THC, nicotine, cotinine, or other drug tests used, and how are conflicting application answers handled [105]?
- How do alcohol use, other prescribed or nonprescribed drugs, psychiatric history, substance-use treatment, criminal history, and driving violations affect eligibility or rating [105]?
- Which legal insurance company will issue the policy in the buyer's state, and what exact policy form and state-specific riders apply [106]?
- What are the guaranteed premium period, renewal premiums, conversion deadline, conversion products, and rider charges [106]?
- Is the quote based on preferred nonsmoker assumptions, and what premium would apply after full disclosure of cannabis use [106]?
- What are the state-specific free-look, cancellation, reinstatement, and lapse provisions [106]?
- Can an independent broker obtain preliminary, anonymous underwriting feedback from Corebridge before submitting a formal application [105]?
- Has Corebridge's underwriting guideline changed since the broker sources were published [117]?
- Does the accidental death rider contain drug or intoxication exclusions that apply to cannabis-related deaths [116]?
Final AI Consensus Verdict
Corebridge Financial is a qualified, mixed-to-good fit for marijuana users, not a specialized cannabis carrier. Five of seven platforms named it during ranking discovery, and platform fit ratings split four "good," two "mixed," and one "uncertain." The strongest case for Corebridge is Select-a-Term: independent sources report Preferred Plus non-tobacco rates for use of 8 or fewer days per month, Standard Non-Smoker rates for use up to several times per week, 18 term-length options, conversion rights, and accelerated underwriting up to $1 million. The strongest case against it is the absence of a published marijuana-specific underwriting manual, conflicting frequency thresholds across sources, a reported vaping penalty to Standard Tobacco rates, reported underwriting tightening in 2024–2025, and conflicting complaint data. Buyers should treat any quote as illustrative until a written, case-specific underwriting indication is obtained, and should compare it against carriers or brokers that publish marijuana-use guidelines.
How This Review Was Produced
This review evaluates Corebridge Financial only for the Life Insurance for Marijuana Users use case. It draws on structured fit-research responses from seven AI platforms (anthropic, deepseek, google, grok, kimi, openai, perplexity), each of which returned a fit rating, use-case findings, pricing and terms, limitations, and questions to verify. Ranking statistics come from the study's ranking stage, where five of seven platforms named Corebridge. All factual claims are cited to the supplied citation IDs. Company-owned sources are distinguished from independent sources in the Sources section. No personal testing, customer experience, or independent verification of carrier underwriting rules was performed.
Methodology Limitations
- All included platforms evaluated fit, but the platform-mention count reflects only platforms that named Corebridge during ranking discovery.
- Platform-reported research dates differ from the authoritative run date of 2026-09-22. Deepseek reported a research date of 2026-06-01; the remaining platforms reported 2026-09-22. Platform-reported dates are provenance metadata and do not independently prove freshness.
- Deepseek ran with search disabled, so its findings are model-reported rather than retrieved.
- The supplied URLs were collected from platform responses and were not independently validated by the writer stage.
- Citations are platform-reported evidence, not independently verified facts.
- Corebridge's public pages describe products and general pricing but do not disclose the current cannabis underwriting manual [118].
- The marijuana rules cited from Nationwide are not Corebridge rules and are included only to demonstrate why frequency, method, disclosure, and related risk factors require direct verification [121].
- The deterministic identity audit noted conflicting official domains and an unresolved identity; the exact legal issuing insurer must be verified on the application and policy.
- Independent reporting identifies complaint and customer-service concerns, and complaint metrics conflict across sources [120].
- Product availability, policy form, issuing insurer, riders, conversion rights, and pricing vary by state [119].
- No verified marijuana-user-specific premium or rate-class information was found [119].
Sources
Company-Owned Sources
- Corebridge Financial official website: https://corebridgefinancial.com/
- Nationwide Life Insurance Underwriting Requirements: https://financial.nationwide.com/media/pdf/NFM-8789AO-MZ.pdf
- Life Insurance for Smokers | Corebridge Direct - Blog: https://www.corebridgedirect.com/content/corebridge-direct/us/en/blog/life-insurance-for-smokers.html
- Request a Quote - Term Life Insurance - Corebridge Direct: https://www.corebridgedirect.com/request-a-quote-term-life-insurance
- Protect your loved ones with affordable term life insurance: https://www.corebridgefinancial.com/content/campaigns/role-based-activity/master/marketing-role-based-activity/emp-exp/term-life-experiencefragment0/jcr:content/par.html
- Corebridge Financial ratings and financial strength: https://www.corebridgefinancial.com/ratings
- Term Life Insurance | Corebridge Financial - Individual: https://www.corebridgefinancial.com/what-we-offer/life-insurance/term-life
- Life Insurance | Corebridge Financial: https://www.corebridgefinancial.com/what-we-offer/life-insurance?role=fp
Additional AI research evidence126 records
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record anthropic:c7
- AI research evidence record perplexity:c5
- AI research evidence record deepseek:c3
- AI research evidence record anthropic:c17
- AI research evidence record anthropic:c6
- AI research evidence record anthropic:c7
- AI research evidence record anthropic:c13
- AI research evidence record kimi:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record anthropic:c14
- AI research evidence record anthropic:c16
- AI research evidence record perplexity:c3
- AI research evidence record anthropic:c8
- AI research evidence record anthropic:c9
- AI research evidence record grok:web:0
- AI research evidence record grok:web:2
- AI research evidence record grok:web:3
- AI research evidence record google:1.1.4
- AI research evidence record perplexity:c1
- AI research evidence record perplexity:c2
- AI research evidence record anthropic:c3
- AI research evidence record kimi:c3
- AI research evidence record anthropic:c1
- AI research evidence record anthropic:c2
- AI research evidence record anthropic:c13
- AI research evidence record kimi:c1
- AI research evidence record google:1.1.7
- AI research evidence record anthropic:c12
- AI research evidence record google:1.1.8
- AI research evidence record google:1.1.9
- AI research evidence record anthropic:c6
- AI research evidence record anthropic:c7
- AI research evidence record perplexity:c5
- AI research evidence record openai:c3
- AI research evidence record deepseek:c3
- AI research evidence record anthropic:c17
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record deepseek:c1
- AI research evidence record perplexity:c1
- AI research evidence record perplexity:c2
- AI research evidence record anthropic:c3
- AI research evidence record kimi:c3
- AI research evidence record kimi:c1
- AI research evidence record google:1.1.4
- AI research evidence record grok:web:2
- AI research evidence record grok:web:3
- AI research evidence record perplexity:c3
- AI research evidence record perplexity:c5
- AI research evidence record perplexity:c6
- AI research evidence record anthropic:c18
- AI research evidence record anthropic:c19
- AI research evidence record anthropic:c8
- AI research evidence record anthropic:c3
- AI research evidence record anthropic:c4
- AI research evidence record grok:web:2
- AI research evidence record grok:web:3
- AI research evidence record anthropic:c10
- AI research evidence record anthropic:c11
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record kimi:c4
- AI research evidence record anthropic:c4
- AI research evidence record anthropic:c8
- AI research evidence record google:1.1.4
- AI research evidence record anthropic:c1
- AI research evidence record anthropic:c2
- AI research evidence record anthropic:c3
- AI research evidence record kimi:c3
- AI research evidence record google:1.1.4
- AI research evidence record grok:web:0
- AI research evidence record anthropic:c13
- AI research evidence record kimi:c1
- AI research evidence record google:1.1.7
- AI research evidence record anthropic:c6
- AI research evidence record anthropic:c7
- AI research evidence record perplexity:c5
- AI research evidence record anthropic:c16
- AI research evidence record perplexity:c3
- AI research evidence record anthropic:c12
- AI research evidence record google:1.1.8
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record anthropic:c3
- AI research evidence record anthropic:c4
- AI research evidence record grok:web:2
- AI research evidence record grok:web:3
- AI research evidence record google:1.1.4
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record deepseek:c1
- AI research evidence record anthropic:c10
- AI research evidence record anthropic:c8
- AI research evidence record anthropic:c18
- AI research evidence record anthropic:c19
- AI research evidence record kimi:c2
- AI research evidence record kimi:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record anthropic:c3
- AI research evidence record anthropic:c5
- AI research evidence record anthropic:c12
- AI research evidence record perplexity:c2
- AI research evidence record anthropic:c11
- AI research evidence record openai:c4
- AI research evidence record deepseek:c1
- AI research evidence record anthropic:c8
- AI research evidence record openai:c3
- AI research evidence record kimi:c4
- AI research evidence record kimi:c1
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record openai:c4
- AI research evidence record anthropic:c18
- AI research evidence record anthropic:c19
- AI research evidence record anthropic:c8
- AI research evidence record deepseek:c1
- AI research evidence record perplexity:c1
Independent Sources
- Cannabis & Life Insurance 2026: AIG, Prudential, MetLife THC Rules: https://cannabisdrugtest.org/cannabis-life-insurance
- Life Insurance for Marijuana Users: The 2026 Ultimate Guide to Non-Smoker Rates: https://cannabisdrugtest.org/life-insurance-for-marijuana-users
- Cannabis Use and Life Insurance | CannabisDrugTest.org: https://cannabisdrugtest.org/situations/insurance
- Marijuana Guidelines - Lovett Financial, Inc: https://lovettfinancial.com/wp-content/uploads/2025/11/Marijuana-Guidelines.pdf
- Life Insurance for Marijuana Users: The 2026 Ultimate Guide to Non-Smoker Rates: https://marcaninsurance.com/life-insurance-marijuana-users-ultimate-guide/
- Life Insurance Field Underwriting Guide - mybackoffice.dmi.com: https://mybackoffice.dmi.com/wp-content/uploads/2024/03/Corebridge.pdf
- CoreBridge Financial | Formerly AIG / American General Life - Term Insurance Brokers: https://terminsurancebrokers.com/life-insurance-answers/corebridge-financial-life-insurance/
- Life Insurance Cannabis: 5 Crucial Tips for 2025 Success: https://www.boston-advisor.com/blog/life-insurance-cannabis
- Corebridge Financial Life Insurance Review 2026 (formerly AIG: https://www.ethos.com/life-insurance/corebridge-financial-life-insurance-review/
- Corebridge Financial Life Insurance Review – Forbes Advisor: https://www.forbes.com/advisor/life-insurance/corebridge-financial-life-insurance-review/
- AIG / Corebridge Financial Life Insurance Review 2026: https://www.insuranceandestates.com/aig-life-insurance-reviews/
- Life insurance and marijuana use: how insurers view cannabis (industry reporting: https://www.investopedia.com/life-insurance-for-marijuana-users-5199515
- Life Insurance and Marijuana: Can You Get Covered?: https://www.moneygeek.com/insurance/life/life-insurance-marijuana/
- Corebridge Life Insurance Review 2026: Pros & Cons: https://www.nerdwallet.com/insurance/life/aig-life-insurance-review
- Life Insurance for Marijuana Users: What You Need to Know – Policygenius: https://www.policygenius.com/life-insurance/marijuana/
- Corebridge Financial Life Insurance Review: Great Term Rates – Policygenius: https://www.policygenius.com/life-insurance/reviews/corebridge-financial/
- Marijuana and Life Insurance: The Guide to Getting Approved - RiskQuoter.com: https://www.riskquoter.com/blog/marijuana-life-insurance/
- Corebridge Financial Life Insurance Review - RiskQuoter.com: https://www.riskquoter.com/company-reviews/corebridge-financial/
- Corebridge Financial Life Insurance (formerly AIG) Review: https://www.wsj.com/buyside/personal-finance/life-insurance/corebridge-financial-life-insurance-review
- Life insurance for Marijuana Users: How It Works and What to Expect: https://www.wsj.com/buyside/personal-finance/life-insurance/life-insurance-for-marijuana-users
Additional AI research evidence126 records
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record anthropic:c7
- AI research evidence record perplexity:c5
- AI research evidence record deepseek:c3
- AI research evidence record anthropic:c17
- AI research evidence record anthropic:c6
- AI research evidence record anthropic:c7
- AI research evidence record anthropic:c13
- AI research evidence record kimi:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record anthropic:c14
- AI research evidence record anthropic:c16
- AI research evidence record perplexity:c3
- AI research evidence record anthropic:c8
- AI research evidence record anthropic:c9
- AI research evidence record grok:web:0
- AI research evidence record grok:web:2
- AI research evidence record grok:web:3
- AI research evidence record google:1.1.4
- AI research evidence record perplexity:c1
- AI research evidence record perplexity:c2
- AI research evidence record anthropic:c3
- AI research evidence record kimi:c3
- AI research evidence record anthropic:c1
- AI research evidence record anthropic:c2
- AI research evidence record anthropic:c13
- AI research evidence record kimi:c1
- AI research evidence record google:1.1.7
- AI research evidence record anthropic:c12
- AI research evidence record google:1.1.8
- AI research evidence record google:1.1.9
- AI research evidence record anthropic:c6
- AI research evidence record anthropic:c7
- AI research evidence record perplexity:c5
- AI research evidence record openai:c3
- AI research evidence record deepseek:c3
- AI research evidence record anthropic:c17
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record deepseek:c1
- AI research evidence record perplexity:c1
- AI research evidence record perplexity:c2
- AI research evidence record anthropic:c3
- AI research evidence record kimi:c3
- AI research evidence record kimi:c1
- AI research evidence record google:1.1.4
- AI research evidence record grok:web:2
- AI research evidence record grok:web:3
- AI research evidence record perplexity:c3
- AI research evidence record perplexity:c5
- AI research evidence record perplexity:c6
- AI research evidence record anthropic:c18
- AI research evidence record anthropic:c19
- AI research evidence record anthropic:c8
- AI research evidence record anthropic:c3
- AI research evidence record anthropic:c4
- AI research evidence record grok:web:2
- AI research evidence record grok:web:3
- AI research evidence record anthropic:c10
- AI research evidence record anthropic:c11
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record kimi:c4
- AI research evidence record anthropic:c4
- AI research evidence record anthropic:c8
- AI research evidence record google:1.1.4
- AI research evidence record anthropic:c1
- AI research evidence record anthropic:c2
- AI research evidence record anthropic:c3
- AI research evidence record kimi:c3
- AI research evidence record google:1.1.4
- AI research evidence record grok:web:0
- AI research evidence record anthropic:c13
- AI research evidence record kimi:c1
- AI research evidence record google:1.1.7
- AI research evidence record anthropic:c6
- AI research evidence record anthropic:c7
- AI research evidence record perplexity:c5
- AI research evidence record anthropic:c16
- AI research evidence record perplexity:c3
- AI research evidence record anthropic:c12
- AI research evidence record google:1.1.8
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record anthropic:c3
- AI research evidence record anthropic:c4
- AI research evidence record grok:web:2
- AI research evidence record grok:web:3
- AI research evidence record google:1.1.4
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record deepseek:c1
- AI research evidence record anthropic:c10
- AI research evidence record anthropic:c8
- AI research evidence record anthropic:c18
- AI research evidence record anthropic:c19
- AI research evidence record kimi:c2
- AI research evidence record kimi:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record anthropic:c3
- AI research evidence record anthropic:c5
- AI research evidence record anthropic:c12
- AI research evidence record perplexity:c2
- AI research evidence record anthropic:c11
- AI research evidence record openai:c4
- AI research evidence record deepseek:c1
- AI research evidence record anthropic:c8
- AI research evidence record openai:c3
- AI research evidence record kimi:c4
- AI research evidence record kimi:c1
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record openai:c4
- AI research evidence record anthropic:c18
- AI research evidence record anthropic:c19
- AI research evidence record anthropic:c8
- AI research evidence record deepseek:c1
- AI research evidence record perplexity:c1
Other Sources
- Marijuana-Usage-Guidelines.pdf: https://lovettfinancial.net/wp-content/uploads/Marijuana-Usage-Guidelines.pdf
- AmericanGeneral_UnderwritingGuide.pdf: https://www.fmiagent.com/wp-content/uploads/BI/MCUG/AmericanGeneral_UnderwritingGuide.pdf?mt_rand(
Additional AI research evidence126 records
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record anthropic:c7
- AI research evidence record perplexity:c5
- AI research evidence record deepseek:c3
- AI research evidence record anthropic:c17
- AI research evidence record anthropic:c6
- AI research evidence record anthropic:c7
- AI research evidence record anthropic:c13
- AI research evidence record kimi:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record anthropic:c14
- AI research evidence record anthropic:c16
- AI research evidence record perplexity:c3
- AI research evidence record anthropic:c8
- AI research evidence record anthropic:c9
- AI research evidence record grok:web:0
- AI research evidence record grok:web:2
- AI research evidence record grok:web:3
- AI research evidence record google:1.1.4
- AI research evidence record perplexity:c1
- AI research evidence record perplexity:c2
- AI research evidence record anthropic:c3
- AI research evidence record kimi:c3
- AI research evidence record anthropic:c1
- AI research evidence record anthropic:c2
- AI research evidence record anthropic:c13
- AI research evidence record kimi:c1
- AI research evidence record google:1.1.7
- AI research evidence record anthropic:c12
- AI research evidence record google:1.1.8
- AI research evidence record google:1.1.9
- AI research evidence record anthropic:c6
- AI research evidence record anthropic:c7
- AI research evidence record perplexity:c5
- AI research evidence record openai:c3
- AI research evidence record deepseek:c3
- AI research evidence record anthropic:c17
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record deepseek:c1
- AI research evidence record perplexity:c1
- AI research evidence record perplexity:c2
- AI research evidence record anthropic:c3
- AI research evidence record kimi:c3
- AI research evidence record kimi:c1
- AI research evidence record google:1.1.4
- AI research evidence record grok:web:2
- AI research evidence record grok:web:3
- AI research evidence record perplexity:c3
- AI research evidence record perplexity:c5
- AI research evidence record perplexity:c6
- AI research evidence record anthropic:c18
- AI research evidence record anthropic:c19
- AI research evidence record anthropic:c8
- AI research evidence record anthropic:c3
- AI research evidence record anthropic:c4
- AI research evidence record grok:web:2
- AI research evidence record grok:web:3
- AI research evidence record anthropic:c10
- AI research evidence record anthropic:c11
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record kimi:c4
- AI research evidence record anthropic:c4
- AI research evidence record anthropic:c8
- AI research evidence record google:1.1.4
- AI research evidence record anthropic:c1
- AI research evidence record anthropic:c2
- AI research evidence record anthropic:c3
- AI research evidence record kimi:c3
- AI research evidence record google:1.1.4
- AI research evidence record grok:web:0
- AI research evidence record anthropic:c13
- AI research evidence record kimi:c1
- AI research evidence record google:1.1.7
- AI research evidence record anthropic:c6
- AI research evidence record anthropic:c7
- AI research evidence record perplexity:c5
- AI research evidence record anthropic:c16
- AI research evidence record perplexity:c3
- AI research evidence record anthropic:c12
- AI research evidence record google:1.1.8
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record anthropic:c3
- AI research evidence record anthropic:c4
- AI research evidence record grok:web:2
- AI research evidence record grok:web:3
- AI research evidence record google:1.1.4
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record deepseek:c1
- AI research evidence record anthropic:c10
- AI research evidence record anthropic:c8
- AI research evidence record anthropic:c18
- AI research evidence record anthropic:c19
- AI research evidence record kimi:c2
- AI research evidence record kimi:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record anthropic:c3
- AI research evidence record anthropic:c5
- AI research evidence record anthropic:c12
- AI research evidence record perplexity:c2
- AI research evidence record anthropic:c11
- AI research evidence record openai:c4
- AI research evidence record deepseek:c1
- AI research evidence record anthropic:c8
- AI research evidence record openai:c3
- AI research evidence record kimi:c4
- AI research evidence record kimi:c1
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record openai:c4
- AI research evidence record anthropic:c18
- AI research evidence record anthropic:c19
- AI research evidence record anthropic:c8
- AI research evidence record deepseek:c1
- AI research evidence record perplexity:c1
Verify this research
Check when the research was run, which platforms were included, and what supports the findings.
- Study date
- September 22, 2026
- Platforms analyzed
- 7
- Source records
- 30
- Ranking mentions
- 5 of 7
- Platform share
- 71%
- Final consensus rank
- #4
Behind the findings
Platforms in this study
- ChatGPT
- Claude
- DeepSeek
- Grok
- Perplexity
- Kimi
- Gemini
Source records
20 independent · 8 company-owned · 2 unclear
Evidence support
23 direct · 7 partial
Keep in mind
Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.
Technical verification details
Use this SHA-256 fingerprint to identify the source snapshot associated with this study.
65d24fc240a80338d1c6f09aae86fe400c92b2045b107b1c405ab4fcaf820ffd